DK0396193T3 - Hundekoronavirusvaccine - Google Patents

Hundekoronavirusvaccine

Info

Publication number
DK0396193T3
DK0396193T3 DK90201081T DK90201081T DK0396193T3 DK 0396193 T3 DK0396193 T3 DK 0396193T3 DK 90201081 T DK90201081 T DK 90201081T DK 90201081 T DK90201081 T DK 90201081T DK 0396193 T3 DK0396193 T3 DK 0396193T3
Authority
DK
Denmark
Prior art keywords
dogs
virus vaccine
corona virus
corona
vaccine
Prior art date
Application number
DK90201081T
Other languages
English (en)
Inventor
William Baxendale
William Stuart Kenned Chalmers
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0396193T3 publication Critical patent/DK0396193T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90201081T 1989-05-03 1990-05-01 Hundekoronavirusvaccine DK0396193T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89304441 1989-05-03

Publications (1)

Publication Number Publication Date
DK0396193T3 true DK0396193T3 (da) 1995-02-27

Family

ID=8202669

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90201081T DK0396193T3 (da) 1989-05-03 1990-05-01 Hundekoronavirusvaccine

Country Status (12)

Country Link
US (2) US5232694A (da)
EP (1) EP0396193B1 (da)
JP (1) JP2892767B2 (da)
KR (1) KR0142081B1 (da)
AU (1) AU630186B2 (da)
CA (1) CA2015828C (da)
DE (1) DE69014974T2 (da)
DK (1) DK0396193T3 (da)
ES (1) ES2068322T3 (da)
HU (1) HU214739B (da)
NZ (1) NZ233509A (da)
ZA (1) ZA903142B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
AU5530498A (en) * 1996-12-18 1998-07-15 Synbiotics Corporation A specific diagnostic for antibodies to feline infectious peritonitis virus
RU2211705C1 (ru) * 2001-12-21 2003-09-10 Федеральное государственное учреждение Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов - центр качества ветеринарных препаратов и кормов Вакцина против коронавирусного энтерита собак
AU2005200757A1 (en) * 2005-02-21 2006-09-07 Peter Henry Scott An Insect Attractant Composition and Trap Containing Same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
EP0138242A1 (en) * 1983-09-07 1985-04-24 Duphar International Research B.V Method of preparing DNA complementary to the genome of coronaviruses
AU7961487A (en) * 1986-08-22 1988-03-08 University Of Texas System, The Human enteric coronavirus
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine

Also Published As

Publication number Publication date
HU214739B (hu) 2000-03-28
ES2068322T3 (es) 1995-04-16
KR900017611A (ko) 1990-12-19
KR0142081B1 (ko) 1998-06-01
JPH02295934A (ja) 1990-12-06
CA2015828A1 (en) 1990-11-03
EP0396193A1 (en) 1990-11-07
US5464621A (en) 1995-11-07
AU5474190A (en) 1990-11-08
ZA903142B (en) 1991-02-27
CA2015828C (en) 1999-07-13
DE69014974D1 (de) 1995-01-26
AU630186B2 (en) 1992-10-22
HU902644D0 (en) 1990-09-28
EP0396193B1 (en) 1994-12-14
HUT56287A (en) 1991-08-28
NZ233509A (en) 1992-05-26
US5232694A (en) 1993-08-03
JP2892767B2 (ja) 1999-05-17
DE69014974T2 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
DE69126606D1 (de) Vakzine
NO930699D0 (no) Hoeyeffektiv vaeske/vaeske hydrosyklon
DK272889D0 (da) Vaccine
FI871362L (fi) Virusvaccin.
DK0452381T3 (da) Malkearrangement
DE69027112D1 (de) Impfstoffzusammensetzung
DK189788D0 (da) Vaccine
FI931272A7 (fi) Droppfaongare
DE69031904D1 (de) Dateiensystem
KR890700356A (ko) 신규의 백신
FI925032L (fi) Vaccinsammansaettningar
BR9004713A (pt) Grampeador
DK1087014T3 (da) Svinepestvirusvaccine og -diagnostik
FI906051A7 (fi) Malariarokote
DE69020848D1 (de) Impfstoff gegen IBV.
ZA903142B (en) Canine corona virus vaccine
DK0381427T3 (da) Vaccinesammensætning
DK375488D0 (da) Vaccine
FI902206A7 (fi) Malariarokote
FI904386A7 (fi) Reunakivi
NO933600D0 (no) Termostabile virus
KR900012042A (ko) 소각로
BR9007246A (pt) Preparacao de vacinas
KR900020392U (ko) 가드레일
DK467187D0 (da) Pseudorabiesvirus-vaccine